Medical Fraud: A Discussion on Race and Class
Understand the debate surrounding medical fraud in South Africa: Did the Section 59 inquiry focus too much on race?
Understand the debate surrounding medical fraud in South Africa: Did the Section 59 inquiry focus too much on race?
An African form of type 1 diabetes challenges existing beliefs about the autoimmune response and its management.
...
Adcock Ingram is set to delist from the JSE as Natco Pharma partners with Bidvest in a major take-private deal.
The NHI dream promises universal health coverage but faces staggering costs. Discover the financial hurdles ahead.
Analyze the claims made in the racial bias report and how they impact perceptions of fairness in medical scheme fraud.